Waist circumference is positively correlated with markers of inflammation and negatively with adiponectin in women with metabolic syndrome

Nutrition Research

Volumn 31, Issue 3, 2011, Pages 197-204

  Ackermann, Daniela ^a   Jones, Jennifer ^a   Barona, Jacqueline ^a   Calle, Mariana C ^a   Kim, Jung Eun ^a   LaPia, Branden ^a   Volek, Jeff S ^a   McIntosh, Mark ^b   Kalynych, Colleen ^b   Najm, Wadie ^c   Lerman, Robert H ^d   Fernandez, Maria Luz ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MetaProteomics LLC   (United States)

Author keywords

Dietary carbohydrates; Glycemic load; Inflammation; Metabolic syndrome; Waist circumference; Women

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GLUCOSE; INSULIN; INTERLEUKIN 6; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CARBOHYDRATE INTAKE; DIETARY FIBER; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC INDEX; GLYCEMIC LOAD; HUMAN; INSULIN RESISTANCE; MACRONUTRIENT; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; NUTRITIONAL ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SUGAR INTAKE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DIET; DIETARY CARBOHYDRATES; FEMALE; GLYCEMIC INDEX; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; METABOLIC SYNDROME X; MIDDLE AGED; WAIST CIRCUMFERENCE;

EID: 79953750691     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.02.004     Document Type: Article

References (51)

1. Hollman G., Kristenson M. The prevalence of the metabolic syndrome and its risk factors in a middle-aged Swedish population-mainly a function of overweight?. Eur J Cardiovasc Nurs 2008, 7:21-26.
2. Wang Y., Mi J., Shan X.Y., Wang Q.J., Ge K.Y. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond) 2007, 31:177-188.
3. Kolovou G.D., Anagnostopoulou K.K., Cokkinos D.V. Pathophysiology of dyslipidaemia in the metabolic syndrome. Postgrad Med J 2005, 81:358-366.
4. Grundy S.M. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008, 28:629-636.
5. Park Y.W., Zhu S., Palaniappan L., Heshka S., Carnethon S.R., Heymsfield S.B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003, 163:427-436.
6. Volek J.S., Fernandez M.L., Feinman R.D., Phinney S.D. Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning and metabolic syndrome. Progress in Lipid Res 2008, 47:307-318.
7. Cornier M.A., Dabelea D., Hernandez T.L., Lindstrom R.C., Steig A.J., Stob N.R., et al. The metabolic syndrome. Endocr Rev 2008, 29:777-822.
8. Lutsey P.L., Steffen L.M., Stevens J. Dietary intake and the development of the metabolic syndrome: the Atherosclerosis Risk in Communities study. Circulation 2008, 117:754-761.
9. Giugliano D., Ceriello A., Esposito K. The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 2006, 48:677-685.
10. Grundy S.M. Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007, 92:399-404.
11. Janssen I., Katzmarzyk P.Y., Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med 2002, 162:2074-2079.
12. Von Eyben F.E., Mouritsen E., Holm J., Montvilas P., Dimcevski G., Suciu G., et al. Intra-abdominal obesity and metabolic risk factors: a study of young adults. Int J Obes Relat Metab Disord 2003, 27:941-949.
13. Snijder M.B., van Dam R.M., Visser M., Seidell J.C. What aspects of body fat are particularly hazardous and how do we measure them?. Int J Epidemiol 2006, 35:83-92.
14. Cartier A., Lemieux I., Almeras N., Tremblay A., Bergeron J., Despres J.P. Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men. J Clin Endocrinol Metab 2008, 93:1931-1938.
15. Trayhurn P., Wood I.S. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004, 92:347-355.
16. Scherer P.E. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006, 55:1537-1545.
17. Sopasakis V.R., Sandqvist M., Gustafson B., Hammarstedt A., Schmelz M., Yang X., et al. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes Res 2004, 12:454-460.
18. Greenberg A.S., Obin M.S. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006, 83:461S-465S.
19. Wellen K.E., Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003, 112:1785-1788.
20. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
21. Al-Sarraj T., Saadi H., Calle M.C., Volek J.S., Fernandez M.L. Carbohydrate restriction as a first-line dietary intervention therapy effectively reduces the biomarkers of metabolic syndrome in Emirati adults. J. Nutr 2009, 139:1667-1676.
22. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
23. Haffner S.M., Miettinen H., Stern M.P. The homeostasis model in the San Antonio Heart Study. Diabetes Care 1997, 20:1087-1092.
24. Despres J.P., Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006, 444:881-887.
25. Abbasi F.B., Brown W., Lamendola C., McLaughlin T., Reaven G.M. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 2002, 40:937-943.
26. Despres J.P. Is visceral obesity the cause of the metabolic syndrome?. Ann Med 2006, 38:52-63.
27. Lapidus L., Bengtsson C., Larsson B., Pennert K., Rybo E., Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) 1984, 289:1257-1261.
28. Kissebah A.H., Vydelingum N., Murray R., Evans D.J., Hartz A.J., Kalkhoff R.K., et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982, 54:254-260.
29. Maffei M., Fei H., Lee G.H., Dani C., Leroy P., Zhang Y., Proenca R., et al. Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. Proc Natl Acad Sci USA 1995, 92:6957-6960.
30. Fox C.S., Massaro J.M., Hoffmann U., Pou K.M., Maurovich-Horvat P., Liu C.Y., et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007, 116:39-48.
31. Panagiotakos D.B., Pitsavos C., Yannakoulia M., Chrysohoou C., Stefanadis C. The implication of obesity and central fat on markers of chronic inflammation: the ATTICA study. Atherosclerosis 2005, 183:308-315.
32. Van Pelt R.E., Evans E.M., Schechtman K.B., Ehsani A.A., Kohrt W.M. Waist circumference vs body mass index for prediction of disease risk in postmenopausal women. Int J Obes Relat Metab Disord 2001, 25:1183-1188.
33. Farin H.M., Abbasi F., Reaven G.M. Body mass index and waist circumference correlate to the same degree with insulin-mediated glucose uptake. Metabolism 2005, 54:1323-1328.
34. Wang Y., Rimm E.B., Stampfer M.J., Willett W.C., Hu F.B. Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 2005, 81:555-563.
35. Canoy D. Distribution of body fat and risk of coronary heart disease in men and women. Curr Opin Cardiol 2008, 23:591-598.
36. Jacobs E.J., Newton C.C., Wang Y., Patel A.V., McCullough M.L., Campbell P.T., et al. Waist circumference and all-cause mortality in a large US cohort. Arch Intern Med 2010, 170:1293-1301.
37. Mahabir S., Baer D.J., Giffen C., Subar A., Campbell W., Hartman T.J., Clevidence B., et al. Calorie intake misreporting by diet record and food frequency questionnaire compared to doubly labeled water among postmenopausal women. Eur J Clin Nutr 2006, 60:561-565.
38. Hu F.B., Manson J.E., Willett W.C. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 2001, 20:5-19.
39. Atkinson F.S., Foster-Power K., Brand-Miller J.C. International tables of glycemic index and glycemic load values. Diabetes Care 2008, 31:3281-33283.
40. Accurso A., Bernstein R.K., Dahlqvist A., Draznin B., Feinman R.D., Fine E.J., et al. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metab (Lond) 2008, 5:9.
41. Volek J.S., Feinman R.D. Carbohydrate restriction improves the features of Metabolic Syndrome. Metabolic Syndrome may be defined by the response to carbohydrate restriction. Nutr Metab (Lond) 2005, 2:31.
42. Wood R.J., Volek J.S., Davis S.R., Dell'Ova C., Fernandez M.L. Effects of a carbohydrate-restricted diet on emerging plasma markers for cardiovascular disease. Nutr Metab (Lond) 2006, 3:19.
43. Volek J.S., Sharman M.J., Forsythe C.E. Modification of lipoproteins by very low-carbohydrate diets. J Nutr 2005, 135:1339-1342.
44. Gonzalez A.S., Guerrero D.B., Soto M.B., Diaz S.P., Martinez-Olmos M., Vidal O. Metabolic syndrome, insulin resistance and the inflammation markers C-reactive protein and ferritin. Eur J Clin Nutr 2006, 60:802-809.
45. Castell J.V., Gomez-Lechon M.J., David M., Fabra R., Trullenque R., Heinrich P.C. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990, 12:1179-1186.
46. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002, 347:1557-1565.
47. Ridker P.M., Buring J.E., Cook N.R., Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 2003, 107:391-397.
48. Han T.S., Sattar N., Williams K., Gonzalez-Villalpando C., Lean M.E., Haffner S.M. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002, 25:2016-2021.
49. Scherer P.E., Williams S., Fogliano M., Baldini G., Lodish H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995, 270:26746-26749.
50. Chandran M., Phillips S.A., Ciaraldi T., Henry R.R. Adiponectin: more than just another fat cell hormone?. Diabetes Care 2003, 26:2442-2450.
51. Lara-Castro C., Fu Y., Chung B.H., Garvey W.T. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol 2007, 18:263-270.